Showing results (51-60 of 127) with videos related to

Sort By:
Pageof 13
Frontiers in Human Neuroscience|June 21, 2013
Parcellation of the cingulate cortex at rest and during tasks: a meta-analytic clustering and experimental studyDiana M E Torta, Tommaso Costa, Sergio Duca, et al.
Bioorganic & Medicinal Chemistry|September 27, 2008
Synergistic effect of basic residues at positions 14-15 of nociceptin on binding affinity and receptor activationKazushi Okada, Kaname Isozaki, Jinglan Li, et al.
The Journal of Biological Chemistry|April 23, 2005
Different structural requirements for the constitutive and the agonist-induced activities of the beta2-adrenergic receptorCaterina Ambrosio, Paola Molinari, Francesca Fanelli, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|November 27, 2002
Structural requirements of nociceptin antagonist Ac-RYYRIK-NH2 for receptor bindingChiaki Kawano, Kazushi Okada, Takeshi Honda, et al.
Bioorganic & Medicinal Chemistry|October 7, 2014
Tritium-labelled isovaleryl-RYYRIK-NH2 as potential antagonist probe for ORL1 nociceptin receptorShogo Inamine, Hirokazu Nishimura, Jinglan Li, et al.
British Journal of Pharmacology|April 6, 2002
Mutations inducing divergent shifts of constitutive activity reveal different modes of binding among catecholamine analogues to the beta(2)-adrenergic receptorRenata Del Carmine, Caterina Ambrosio, Maria Sbraccia, et al.
Bioorganic & Medicinal Chemistry|December 11, 2007
Designed modification of partial agonist of ORL1 nociceptin receptor for conversion into highly potent antagonistJinglan Li, Kaname Isozaki, Kazushi Okada, et al.
Cerebral Cortex (New York, N.Y. : 1991)|May 4, 2018
Action Observation Areas Represent Intentions From Subtle Kinematic FeaturesAtesh Koul, Andrea Cavallo, Franco Cauda, et al.
The Journal of Biological Chemistry|July 10, 2013
Ligands raise the constraint that limits constitutive activation in G protein-coupled opioid receptorsVanessa Vezzi, H Ongun Onaran, Paola Molinari, et al.
Pageof 13